ALOPECIA TREATMENT MARKET ANALYSIS

Alopecia Treatment Market, By Drug Class (Corticosteroids, 5 AR Inhibitors, Vasodilators, Others), By Disease Type (Alopecia Areata, Androgenic Alopecia, Traction Alopecia, Others), By Route of Administration (Topical, Oral, Injectable Topical application), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), By geography (North America, Latin America, Europe, Asia Pacific, Middle East & Africa)

Global Alopecia Treatment Market: Key Developments

In June 2023, Cosmo Pharmaceuticals N.V., a pharmaceutical company, announced the initation of the phase III trials of clascoterone solution in males for the treatment of androgenetic alopecia (AGA).
In March 2022, Triple Hair Group Inc., a company specializing in the development of innovative treatments for alopecia, announced the online launch of Plenty NaturalTM, a brand of patented and clinically proven natural hair growth products for women. In addition to its functional features, this product line helps strengthen, thicken and increase hair density, for healthier, fuller-looking hair.

Global Alopecia Treatment Market: Key Trends

Increasing fund raising for alopecia treatment: Increasing fund raising for alopecia treatment in the market is expected to drive the growth of the global alopecia treatment market over the forecast period. For instance, in July 2021, Stemson Therapeutics, a U.S.-based pre-clinical stage cell therapy company, closed US$ 15 Mn Series A financing. The company intends to use the funds to advance development of its proprietary therapeutic solution to cure hair loss. The iPSC-derived cells are used to grow de novo hair follicles, offering a new supply of hair to treat people suffering from various forms of alopecia